Effect of Cell Culture Medium on the Proliferation and Stemness of CD24-/CD44+ Human Breast Cancer Stem Cells

被引:3
|
作者
Nadia, Yalista Fatia [1 ]
Syahrani, Resda Akhra [2 ]
Arumsari, Sekar [2 ]
Sadikin, Mohamad [3 ]
Wanandi, Septelia Inawati [2 ,3 ]
机构
[1] Univ Indonesia, Fac Med, Masters Programme Biomed Sci, Jl Salemba Raya, Jakarta 10430, Indonesia
[2] Univ Indonesia, Fac Med, Molectdar Biol & Protc Core Facil, Indonesian Med Educ & Res Inst IMERI, Jl Salemba Raya, Jakarta 10430, Indonesia
[3] Univ Indonesia, Fac Med, Dept Biochem & Mol Biol, Jl Salemba Raya, Jakarta 10430, Indonesia
来源
INDONESIAN BIOMEDICAL JOURNAL | 2021年 / 13卷 / 04期
关键词
breast cancer; cancer stem cell; OCT4; stemness; proliferation; TARGET; HEPES;
D O I
10.18585/inabj.v13i4.1674
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND: Cancer stem cells (CSCs) is defined as tumor initiating cells within tumor that maintain stemness properties and tumorigenicity. Extracellular pH of CSCs in in vitro condition is important for supporting cell proliferation which may also regulate the expression of stemness markers such as OCT4. This work aimed to examine the effect of cell culture media on the proliferation and stemness of human breast cancer stem cells (BCSCs). METHODS: Human CD24(-)/CD44(+) BCSCs were grown in Dulbecco's Modified Eagle Medium/F-12 (DMEM/F-12) with 15mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), without HEPES and adjusted to pH 7.4, or without HEPES but pH was not adjusted. BCSCs were grown under standard conditions for various days. Viable cell number was measured using trypan blue exclusion, whereas proliferation rate using MTS assay. OCT4 mRNA and protein were analyzed using quantitative real time PCR (qRT-PCR) and Western Blot assay, respectively. In vitro tumorigenic activity was determined using mammosphere formation unit (MFU) assay. RESULTS: Our results showed a higher viable cell number and proliferation of BCSCs in DMEM/F-12 HEPES (-) compared to HEPES (+) medium until 4 day incubation. OCT4 mRNA and protein level, as well as MFU of BCSCs were significantly higher in HEPES (-) compared to HEPES (+) medium on day 2. CONCLUSION: DMEM/F-12 medium without HEPES facilitates CD24(-)/CD44(+) BCSCs to have higher proliferation and stemness on day 2 incubation compared to those with HEPES.
引用
收藏
页码:355 / 363
页数:9
相关论文
共 50 条
  • [21] p63 inhibits CD44+/CD24- cell proliferation and chemoresistance in papillary thyroid carcinoma cells
    Guo, Jing-Jing
    Xu, Hong-Shun
    Wu, Gang
    Ma, Zhen-Yu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) : 4693 - 4696
  • [22] The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast
    Li, Weidong
    Liu, Fangfang
    Lei, Ting
    Xu, Xinsheng
    Liu, Bingbing
    Cui, Lifang
    Wei, Jia
    Guo, Xiaojing
    Lang, Ronggng
    Fan, Yu
    Gu, Feng
    Tang, Ping
    Zhang, Xinmin
    Fu, Li
    PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (12) : 828 - 834
  • [23] The clinicopathologic and prognostic significance of CD44+/CD24-/low and CD44-/CD24+ tumor cells in invasive breast carcinomas
    Mylona, Eleni
    Giannopoulou, Ioanna
    Fasomytakis, Emmanouil
    Nomikos, Alexandros
    Magkou, Christina
    Bakarakos, Panagiotis
    Nakopoulou, Lydia
    HUMAN PATHOLOGY, 2008, 39 (07) : 1096 - 1102
  • [24] CD44+/CD24- breast cancer cells exhibit enhanced invasive properties:: an early step necessary for metastasis
    Sheridan, Carol
    Kishimoto, Hiromitsu
    Fuchs, Robyn K.
    Mehrotra, Sanjana
    Bhat-Nakshatri, Poornima
    Turner, Charles H.
    Goulet, Robert, Jr.
    Badve, Sunil
    Nakshatri, Harikrishna
    BREAST CANCER RESEARCH, 2006, 8 (05):
  • [25] CD44+/CD24- phenotype predicts a poor prognosis in triple-negative breast cancer
    Wang, Hui
    Wang, Li
    Song, Ying
    Wang, Shuhuai
    Huang, Xu
    Xuan, Qijia
    Kang, Xinmei
    Zhang, Qingyuan
    ONCOLOGY LETTERS, 2017, 14 (05) : 5890 - 5898
  • [26] Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms
    GeórgiaModé Magalhães
    ErikaMaria Terra
    Rosemeri de Oliveira Vasconcelos
    Márcio de Barros Bandarra
    PamelaRodriguesReina Moreira
    Mayara Caroline Rosolem
    Antonio Carlos Alessi
    BMC Veterinary Research, 9
  • [27] miR-205/RunX2 axis negatively regulates CD44+/CD24- breast cancer stem cell activity
    Zhang, Lu
    Liu, Lei
    Xu, Xiaodan
    He, Xiaogang
    Wang, Gang
    Fan, Chulin
    Zheng, Qiping
    Li, Feifei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (06): : 1871 - 1887
  • [28] Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
    Mendez, Lisbeth Escudero
    Srinivasan, Mirra
    Hamouda, Ranim K.
    Ambedkar, Baba
    Arzoun, Hadia
    Sahib, Isra
    Fondeur, Jack
    Mohammed, Lubna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [29] CD44+/CD24-/low cells derived from long-term cultured human breast carcinosarcoma
    Han, W.
    Lee, K. M.
    Kim, J. B.
    Ko, E.
    EJC SUPPLEMENTS, 2008, 6 (07): : 99 - 100
  • [30] The CD44+/CD24- phenotype is enriched in basal-like breast tumors
    Honeth, Gabriella
    Bendahl, Par-Ola
    Ringner, Markus
    Saal, Lao H.
    Gruvberger-Saal, Sofia K.
    Lovgren, Kristina
    Grabau, Dorthe
    Ferno, Marten
    Borg, Ake
    Hegardt, Cecilia
    BREAST CANCER RESEARCH, 2008, 10 (03)